INSPIOLTO RESPIMAT DIN 02441888
Status: Marketed
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Available to quote
Health Canada record
| Active ingredient(s) | TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 2.5 MCG; OLODATEROL (OLODATEROL HYDROCHLORIDE) 2.5 MCG |
|---|---|
| Dosage form | Solution |
| Route | Inhalation |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | R03AL06 OLODATEROL AND TIOTROPIUM BROMIDE |
| Original market date | 29-May-2015 |
| Current status date | 29-May-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02550865 | APO-TIOTROPIUM | APOTEX INC | Capsule | TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 18 MCG | Marketed |
| 02537850 | LUPIN-TIOTROPIUM | LUPIN PHARMA CANADA LIMITED | Capsule | TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 18 MCG | Marketed |
| 02246793 | SPIRIVA | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Capsule | TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 18 MCG | Marketed |
| 02435381 | SPIRIVA RESPIMAT | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Solution | TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) 2.5 MCG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16940 | 2015-05-28 | New Drug Submission (NDS) |